{
    "body": "The protein neprilysin  has an positive effect on Alzheimer disease, how can it be delivered to the brain?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23378928", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22751177", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20817034", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17760499", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22114052", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21304989", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23503602", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19469700"
    ], 
    "ideal_answer": [
        "The protein neprilysin can be deliverered to the brain (crossing the blood brain barrier) through: gene tranfer, transgenesis, gene induction, ex-vivo gene therapy, intracardiac (peripheral) administration of viral neprilysin construct, syringe-focused ultrasound device, convection-enhanced delivery and the use of human adipose tissue-derived mesenchymal stem cells that secrete functional neprilysin-bound exosomes"
    ], 
    "exact_answer": [
        [
            "Gene transfer with viral vectors"
        ], 
        [
            "Gene transfer with non-viral vectors"
        ], 
        [
            "Transgenesis"
        ], 
        [
            "Gene Induction"
        ], 
        [
            "Fusion of the Apolipoprotein B (ApoB) low-density lipoprotein (LDL) receptor-binding domain to a targeted protein"
        ], 
        [
            "ex vivo gene therapy"
        ], 
        [
            "Intracardiac (peripheral) administration of viral neprilysin construct"
        ], 
        [
            "Syringe-focused ultrasound device"
        ], 
        [
            "Convection-enhanced delivery"
        ], 
        [
            "Use of human adipose tissue-derived mesenchymal stem cells that secrete functional neprilysin-bound exosomes"
        ]
    ], 
    "concepts": [
        "http://www.uniprot.org/uniprot/NEP_HUMAN", 
        "http://www.disease-ontology.org/api/metadata/DOID:10652", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016503", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018014", 
        "http://www.uniprot.org/uniprot/NEP_RABIT", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015260", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D023582", 
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000544"
    ], 
    "type": "list", 
    "id": "5162e44f298dcd4e5100004a", 
    "snippets": [
        {
            "offsetInBeginSection": 641, 
            "offsetInEndSection": 816, 
            "text": "he novel, syringe-focused US device was used to introduce purified plasmid DNA encoding human neprilysin (hNEP) into mouse hindlimb skeletal muscle concurrent with US protocol", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22114052", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 1494, 
            "offsetInEndSection": 1673, 
            "text": "This technique provides a safe and efficient non-viral method for in vivo gene delivery with potential applications in both basic research and in gene therapy of neuronal disease.", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20817034", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 78, 
            "text": "A novel system for in vivo neprilysin gene delivery using a syringe electrode.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20817034", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 97, 
            "offsetInEndSection": 257, 
            "text": "Previous studies have demonstrated the therapeutic potential of viral vector-mediated neprilysin (NEP) gene therapy in mouse models of Alzheimer's disease (AD).", 
            "beginSection": "sections.0", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22751177", 
            "endSection": "sections.0"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 93, 
            "text": "Convection-enhanced delivery of neprilysin: a novel amyloid-\u03b2-degrading therapeutic strategy.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22751177", 
            "endSection": "title"
        }
    ]
}